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Background: Mutations of the UDP-N-acetylglucosamine-2-epimerase/N-acetylmannosamine-kinase (GNE)-gene are
causally related to GNE myopathy. Yet, underlying pathomechanisms of muscle fibre damage have remained
elusive. In sporadic inclusion body myositis (sIBM), the pro-inflammatory cell-stress mediators αB-crystallin and
inducible nitric oxide synthase (iNOS) are crucial markers of the disease pathology.
Methods: 10 muscle biopsies from GNE myopathy patients were analyzed for mRNA-expression of markers of
cell-stress, inflammation and β-amyloid and compared to non-myopathic controls. Using double-labeling
immunohistochemistry, serial sections of skeletal muscle biopsies were stained for amyloid precursor protein (APP),
major histocompatibility complex (MHC)-I, αB-crystallin, neural cell adhesion molecule (NCAM), interleukin (IL)-1β,
β-amyloid, iNOS, and phosphorylated neurofilament (P-neurofilament) as well as hematoxylin/eosin histochemistry.
Corresponding areas of all biopsies with a total of 2,817 muscle fibres were quantitatively assessed for all markers.
Results: mRNA-expression of APP, NCAM, iNOS, TNF-α and TGF-β was higher in GNE myopathy compared to
controls, yet this was not statistically significant. The mRNA-expression of APP and αB-crystallin significantly
correlated with the expression of several pro-inflammatory and cell-stress-associated markers as NCAM, IL-1β, TGF-β,
CCL-3, and CCL4. By immunohistochemistry, αB-crystallin and iNOS were co-upregulated and the number of fibres
positive for αB-crystallin, NCAM, MHC-I and iNOS significantly correlated with each other. A large fraction of fibres
positive for αB-crystallin were double positive for iNOS and vice-versa. Moreover, several fibres with structural
abnormalities were positive for αB-crystallin and iNOS. Notably, particularly normal appearing fibres displayed an
overexpression of these molecules.
Conclusions: The cell-stress molecules αB-crystallin and iNOS are overexpressed in GNE myopathy muscle and may
identify early disease mechanisms. The data help to better understand the pathology of GNE myopathy.
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GNE myopathy has previously been also termed
quadriceps sparing myopathy, hereditary inclusion
body myopathy, or distal myopathy with rimmed vacu-
oles. It is a slowly progressive myopathy that leads to
wasting and weakness of distal and proximal muscles
[1,2]. The disease mostly begins between the second and
fourth decade of life and patients often loose ambulation
after a disease course of 12 years or later [3]. Typical* Correspondence: j.schmidt@gmx.org
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reproduction in any medium, provided the orhallmarks of the muscle pathology include formation of
vacuoles and tubulofilamentous inclusions by electron
microscopy [4]. So far no treatment is available to
effectively ameliorate the disease progression [5,6].
Various mutations have been identified in the UDP-N-
acetyl-glucosamine 2-epimerase/N-acetylmannosamine
kinase (GNE)-gene, a key enzyme of sialylation which is
believed to be a major causative factor of the disease
pathology [7,8]. Accordingly, mice with a knockout
of the GNE gene develop a myopathy with features
of GNE myopathy [9]. Moreover, there is evidence of
hyposialylation in myoblasts from patients with GNE
myopathy [10], yet the precise mechanism of howLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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yet remained elusive.
Inflammation is normally not present in GNE myopathy,
although it is a typical hallmark in sporadic inclusion
body myositis (sIBM), where it was recently shown that
β-amyloid-associated molecules correlate with overexpression
of inflammatory mediators [11]. Cell stress molecules such
as αB-crystallin and nitric oxide (NO) have recently been
identified in conjunction with the β-amyloid-associated
pathology of sIBM [12,13]. NO can be produced in large
amounts by inducible nitric oxide synthase (iNOS),
which can be particularly upregulated under inflammatory
conditions [14]. In view of previous evidence of a unique
role of NO in GNE myopathy [15,16], we here searched
for pro-inflammatory cell stress molecules in the muscle
of GNE myopathy patients.
Methods
Patients and muscle biopsies
Diagnostic biopsies were used from skeletal muscle of 10 pa-
tients with GNE-mutations between 23–49 years of age, mean
age of 33, six women and four men (Table 1). All samples were
taken from the collection of the Department of Neuromuscu-
lar Research, National Center of Neurology and Psychiatry,
National Institute of Neuroscience, Tokyo, Japan.
For the non-myopathic control group, nine muscle specimen
were chosen from diagnostic muscle biopsies or orthopedic
surgery at the University Medical Center, Göttingen, Germany:
We used samples from six women and three men of 41–73
years of age, mean age of 52. The study was approved by
the ethics committee of the Universities of Göttingen and
Tokyo; an informed consent was not required.
Extraction of RNA and quantitative PCR
Total RNA was extracted from muscle biopsies using a
kit (RNeasy from Qiagen, Valencia, CA, USA), following
the supplier’s instructions. The tissue was homogenized
with a plastic tissue grinder and pestle (Kontes GlassTable 1 List of patients with GNE myopathy
Patient Age Gender Mutation
1 >30 F D176V A630T
2 ≤30 M V572L V572L
3 >30 F V572L V572L
4 ≤30 M D176V V331A
5 ≤30 F V572L V572L
6 >30 M V572L c.769 + 4A > G (exon4 skipping)
7 ≤30 M V572L V572L
8 ≤30 F V572L V572L
9 >30 F D176V V572L
10 >40 M D176V D176V
The age range at biopsy, gender and mutation details are indicated.Company, Vineland, NJ, USA) in 350 μl lysis buffer and
the RNA was eluted in 30 μl water and stored at −80°C.
cDNA synthesis from 200 ng RNA was carried out using
SuperScript II reverse transcriptase (Invitrogen, Darmstadt,
Germany), following the supplier’s instructions. Originated
cDNA was stored at −20°C and amplified in a 20 μl
reaction volume with master mix for real-time PCR
(Invitrogen) using 6-carboxy-fluorescein (FAM)-labelled
probes and specific primers (Applied Biosystems, Carlsbad,
CA, USA): Glyceraldehyde-3-phosphate dehydrogenase
(GAPDH, s99999905_m1); APP (Hs00169098_m1), TGF-β1
(Hs00171257_m); IL-1β (Hs00174097_m1); CCL-3
(Hs00234142_m1); ubiquitin (Hs00430290_m1); CXCL-9
(Hs00171065_m1); αB-crystallin (Hs00157107_m1); NCAM
(Hs00169851_m1); desmin (Hs00157258_m1); CCL-4
(Hs00605740_g1); IFN-γ (Hs00174143_m1); TNF-α
(Hs00174128_m1); IL-6 (Hs00174131_m1) iNOS
(Hs00167257_m1); MHC-I (custom design: forward 5’-
TGG AGT GGC TCC GCA GAT AC-3’; reverse 5’-AGT
GTG ATC TCC GCA GGG TAG A-3’). Reactions were
performed in duplicates on a SDS 7500 Sequence Detection
System (Applied Biosystems), following the standard cycle
protocol and instructions given by the supplier. The
resulting mRNA-expression was quantified using the Δc(t)
method in relation to expression of GAPDH mRNA.
Staining of muscle tissue
For immunohistochemistry, 5 μm frozen sections of
all muscle biopsies were fixed either in PFA-methanol
(4% PFA for 10 min, followed by methanol for 10 min)
for iNOS and P-neurofilament (SMI-31) or in acetone
at −20°C for 10 min for all other primary antibodies.
Unspecific binding was reduced by 30 min incubation
with 5% bovine serum albumin (BSA) and 3% goat serum
(all from Jackson ImmunoResearch, West Grove, PA) in
PBS. All primary and secondary antibodies were diluted in
1% BSA. Following primary antibodies were used at the
respective concentration with an incubation time of
one hour at room temperature unless stated otherwise:
β-amyloid (mouse clone 6E10, Signet, Dedham, MA) at
10 μg/ml for 24 hours at 4°C; MHC class I (rat clone
YTH 862.2 from Serotec, Oxford, UK) at 5 μg/ml; APP
(rabbit polyclonal from Serotec, Oxford, UK) at 10 μg/ml;
iNOS (rabbit polyclonal from Chemicon/Millipore,
Billerica, MA) at 1/500 dilution; NCAM (mouse clone
Eric-1 from Labvision/Neomarkers, Fremont, CA) at
2 μg/ml; αB-crystallin (rabbit polyclonal from Serotec) at
1/1000 dilution; P-neurofilament (mouse clone SMI-31
from Covance, Princeton, NJ, USA) at 0.5 μg/ml; IL-1β
(rabbit polyclonal from Abcam, Cambridge, USA) at 1/100
dilution for 24 hours at 4°C.
Consecutive sections of all GNE myopathy patients
were double-labelled for 1) APP and MHC-I; 2) NCAM
and αB-crystallin; 3) IL-1β and β-amyloid; 4) iNOS and
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Secondary reagents were goat-derived Alexa 594 or
Alexa 488 secondary antibodies. Nuclear counterstaining
was performed by DAPI for 45 s at 1:50/000, followed by
mounting in Fluoromount G (Southern Biotech, Alabama,
USA). Digital photography was performed on a Zeiss
Axiophot microscope (Zeiss, Göttingen, Germany), using
appropriate filters for green (488 nm), red (594 nm) and
blue (350 nm) fluorescence, a cooled CCD digital camera
(Retiga 1300, Qimaging, Burnaby, BC, Canada) and the
ImageProPlus software (MediaCybernetics, Bethesda, MD).
Microphotographs of representative and corresponding
areas of all serial sections were taken from each patient’s
sample, yielding between 107 and 498 muscle fibres
per patient. The expression of the respective markers
was manually identified in a total of 2,817 fibres of all
serial sections. A positive staining of individual fibers
was judged by comparison with the signal intensities of
the same biopsy, other samples from GNE-patients as
well as normal control tissue.
Statistics
For statistical analysis (t-test, Pearson correlation),
*P < 0.05, **P < 0.01 and ***P < 0.001 were used as signifi-
cant values and all significant outliers (Grubb’s test) were
excluded prior to analysis (Graph Pad Prism V4, San Diego,
CA, USA).
Results
mRNA-expression of disease relevant markers in GNE
myopathy muscle compared to controls
Relevant markers of the β-amyloid-pathway (APP, UBB),
muscle degeneration/regeneration (desmin/NCAM),
cell-stress (αB-crystallin, MHC-I, iNOS) and inflammation
(IFN-γ, IL-1β, IL-6, TNF-α, TGF-β, CXCL-9, CCL-3, CCL-4)
as recently analyzed in sIBM and other inflammatory
myopathies and non-inflammatory muscular dystrophy
[11] were measured by quantitative PCR. All markers were
detectable in GNE myopathy and the highest mean values
of expression were noted for the degeneration-/cell stress
associated markers αB-crystallin (1.052), desmin (0.315),
ubiquitin (0.263), and APP (0.0226) (Figure 1). The
mean expression of MHC-I remained at a slightly lower
level (0.00925). The fibrosis-associated cytokine TGF-β
(0.000407) and the chemokine CXCL-9 (0.000345)
displayed a moderate expression level, whereas all
other inflammatory mediators and NCAM (0.0494) were
expressed at lower levels in most patients. Compared to
non-myopathic control muscle, a higher mean expression
was noted for APP, NCAM, MHC-I, TNF-α, and TGF-β,
but no statistical significance was reached.
To address interrelationships between β-amyloid associ-
ated markers, cell-stress and inflammation, we performed a
correlation analysis. As expected, the mRNA-expression ofAPP significantly correlated with the tagging molecule
ubiquitin (Figure 2A). Moreover, APP was significantly
associated with the cell-stress molecule MHC-I and the
chemokines CCL-3 and CCL-4. Other markers remained
without significant association with APP (not shown). The
mRNA-expression of the heat shock protein αB-crystallin
significantly correlated with desmin, a marker used to
identify e.g. degeneration/regeneration, with the cytokine
IL-6, and the chemokine CCL-4 (Figure 2B). Other associa-
tions with αB-crystallin did not reach statistical significance
(not shown). Within the group of inflammatory mediators,
the mRNA-expression of TGF-β significantly correlated
with CCL-3 (r = 0.9786, P = 0.0007), CCL-4 (r = 0.9469,
P = 0.0042) and TNF-α (r = 0.9080, P = 0.0123) (not shown).
No obvious association between the most prevalent muta-
tion V572L vs. other mutations and any of the pathologic
markers was noted (not shown).
Collectively, these data demonstrate that markers of
β-amyloid-associated pathology, cell-stress and inflam-
mation are present in GNE myopathy muscle and sig-
nificantly correlate with each other, albeit no significant
overexpression could be observed.
Protein expression of relevant markers of the disease
Protein expression was analyzed by serial staining of
sections from biopsies of all GNE myopathy patients
with immunohistochemical double labeling of 1) APP
and MHC-I, 2) αB-crystallin and NCAM, 3) IL-1β and
β-amyloid, and 4) iNOS and P-neurofilament. In a
consecutive fifth section, histochemical staining for H&E
was performed (Figure 3). By photomicroscopy and
manual analysis, all entire cross sections of all 5 stainings
from all GNE myopathy patients were quantified with an
analysis of a total of 2,817 fibers. The two markers with
the highest rate of positive fibers were αB-crystallin with
10.2 ± 2.0% (mean ± standard error) of all fibers and iNOS
with 16.3 ± 3.2% of all fibers. NCAM was overexpressed
in 4.8 ± 2.4% and P-neurofilament in 3.8 ± 1.5%, whereas
APP, β-amyloid, MHC-I and IL-1β displayed a much
lower expression (Figure 4A). A subtype analysis revealed
that over a third of the fibers positive for αB-crystallin
were double-positive for NCAM (33.8 ± 10.5%) and that
23.5 ± 6.2% were double-positive for iNOS. On the other
hand, 15.9 ± 3% of the iNOS-positive fibers were
double-positive for αB-crystallin and 10.7 ± 4.1% for
NCAM. All other markers remained at a lower level. To
further address the relevance of cell stress molecules,
the correlation of their overexpression as reflected by
immunohistochemistry was statistically analyzed. The
number of fibers positive for the cell stress molecules
iNOS and αB-crystallin highly significantly correlated
with each other as well as with MHC-I and NCAM
(Figure 4B). No significant association was observed for












































































Figure 1 mRNA-Expression of markers of inflammation, degeneration, regeneration and pro-inflammatory cell stress. The mRNA-
expression relative to GAPDH was quantified in all GNE myopathy samples compared to non-myopathic controls. The mean expression of APP,
NCAM, MHC-I, TNF-α and TGF-β is higher in GNE myopathy compared to controls, but no statistical significance is reached.
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any of the pathologic markers was noted (not shown).
Collectively, these data show that αB-crystallin and
iNOS are the most prevalent cell stress markers in GNE
myopathy muscle and that they significantly correlate
and/or co-localize with other markers of inflammation
and cell stress.
Subtype analysis of fibers with or without structural
abnormalities
To evaluate early cell stress mechanisms in GNE myop-
athy muscle, the upregulation of all relevant markers
was analyzed in fibers that did not display any signs of
morphological abnormalities (Figure 5). The only two
markers that were noticeably overexpressed were αB-
crystallin (5.5 ± 1.3%) and iNOS (10.7 ± 2.8%). 11.7% of
the fibers positive for αB-crystallin were double positive
for iNOS (data not shown). The other markers remained
at a lower level. To further address interrelationships
between cell-stress molecules, protein aggregation and
muscle degeneration, a subtype analysis of fibers with
signs of atrophy or hypertrophy was performed. In
atrophic fibers, an overexpression was observed for
αB-crystallin with 24.4 ± 4.7% positive fibers as well as
for iNOS with 21.5 ± 7.0% of the fibers (Figure 6A),
whereas all other markers remained at a lower level. In
vacuolated fibers, αB-crystallin was present in a fraction of20.2 ± 9.3%, followed by iNOS with 11.8 ± 8.8% (Figure 6B);
all other markers were not noticeably upregulated. In
hypertrophic fibers, the level of overexpression of iNOS
(8 ± 2.5%), P-neurofilament (6.8 ± 4.8%) and αB-crystallin
(6.8 ± 3.9%) were comparably elevated in contrast to
all other markers that remained at a negligible level
(Figure 6C).
Collectively, these data demonstrate that iNOS and
αB-crystallin are present in normal appearing fibers and
may precede subsequent morphological changes including
atrophy, hypertrophy and vacuolar transformation.
Discussion
We here demonstrate that αB-crystallin and iNOS are
relevant cell stress markers in the muscle fibers of GNE
myopathy patients. They are upregulated in normal
appearing fibers as well as in those that had undergone
atrophy, hypertrophy or vacuolar transformation.
Pro-inflammatory cytokines and chemokines were
expressed at levels comparable to control muscles,
but some of these mediators were significantly associated
with the markers for cell-stress or β-amyloid-associated
degeneration. Collectively, our data suggest that a pro-
inflammatory cell stress response with overexpression
of αB-crystallin and iNOS is present in GNE myopathy
muscle and precedes muscle degeneration with accu-
mulation of β-amyloid.
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Figure 2 Correlation analysis of mRNA- expression in GNE myopathy muscle. The mRNA-expression of each marker from all GNE myopathy
samples was correlated to other markers (data from Figure 1). A) The mRNA-expression of APP significantly correlates with that of UBB, MHC-I,
CCL3 and CCL4. B) A significant correlation is observed between the cell stress marker αB-crystallin and desmin, IL-6 and CCL-4.
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morphologically normal fibers is very similar to what has
previously been demonstrated in sIBM [12,17] and
suggests that an early underlying cell stress response is
active in GNE myopathy. Since αB-crystallin has been
shown to be important to protect from accumulation of
unwanted proteins such as β-amyloid in muscle as well
as in the brain [18-20], it is possible that muscle fibers
upregulate αB-crystallin in order to downmodulate
toxicity of APP and/or oligomers of β-amyloid, which
may be present in muscle fibers even in absence of
vacuoles or inclusion bodies [12]. This is in line with
previous evidence that overexpression of APP in muscle
cells led to an upregulation of αB-crystallin [21]. One
fifth of the fibers with signs of an end-stage pathology
with atrophic morphology and/or vacuoles were accom-
panied by an overexpression of αB-crystallin. This further
substantiates that, once a cell stress response is instigatedin the cells, a subsequent detrimental accumulation of
unwanted proteins including β-amyloid will follow. Such
an association of protein accumulation and αB-crystallin
has previously been demonstrated in the skeletal muscle
from patients with other myopathies [22].
Our data demonstrate that NO-related cell stress is
present in muscle fibers of GNE myopathy patients,
which is in line with previous reports [15,16]. This cell
stress response does not appear to be specific to GNE
myopathy, but could be an underlying event with rele-
vance to other myopathies: In sIBM, NO has recently
been demonstrated to play an important pathogenic role as
evidenced by an upregulation of the key NO-producing
enzyme iNOS in muscle cells exposed to pro-inflammatory
cytokines [13]. In other forms of myositis there is a similar
production of NO upon overexpression of iNOS [23-25],
which can be upregulated in response to inflammation.









Figure 3 Fluorescent immunohistochemical double-labelling of serial sections in GNE myopathy muscle biopsy specimen. A representative
GNE myopathy sample is shown with five consecutive sections that were stained for hematoxylin/eosin (first row); APP (red) and MHC-I (green)
(second row); αB-crystallin (red) and NCAM (green) (middle row); IL-1β (red) and β-amyloid (green) (fourth row); iNOS (red) and P-neurofilament
(green) (last row). The highest number of positive staining signal is noted for iNOS, followed by αB-crystallin and NCAM. All other markers are present
only in very few fibers.
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http://www.biomedcentral.com/1471-2377/13/24muscle fibers themselves can produce chemokines and
cytokines [11], it is generally possible that a similar
overexpression of inflammatory mediators also occurs in
GNE-myopathy, even in absence of cellular infiltration.
Yet other triggering events are likely to be more relevant
in this disorder. It is even possible that NO-stress isa secondary event to accumulation of APP/β-amyloid,
which would be supported by previous evidence of co-
localization of oxidative stress related molecules with
vacuoles and intracellular aggregation of proteins such
as β-amyloid [16,26]. However, this would be in contrast

































































































































































































































Figure 4 Quantitative assessment of immunohistochemical staining in GNE myopathy. The serial stainings as in Figure 3 were
quantitatively assessed in all GNE myopathy samples. A) Percentages of all fibres positive for markers of degeneration, inflammation and cell
stress in GNE myopathy (left panel, note the highest values for αB-crystallin and iNOS). Subtype analysis of fibres positive for αB-crystallin and
iNOS (both panels on the right). Data presented as mean plus SEM. B) Correlation analysis of fibres positive for αB-crystallin, NCAM, MHC-I and
iNOS by immunohistochemical staining demonstrates a significant association between these markers.
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and, thus, likely precedes vacuolar transformation and
protein aggregation. On the other hand it is possible
that vacuoles are already present at a different location
within the same fiber.
A large fraction of morphologically normal fibers were
double positive for αB-crystallin and iNOS, which
further suggests that, similar to sIBM, an underlying cell
stress response is operative in GNE myopathy muscle
fibers. It is possible that similar triggers exist for an
overexpression of αB-crystallin as well as for intrafiber-
production of NO, but it cannot be excluded that onefollows the other, e.g. that intracellular NO-toxicity leads
to an overexpression of αB-crystallin and vice versa. The
precise underlying conditions that lead to intracellular
damage in GNE myopathy have yet remained elusive. A
recent report has demonstrated that impaired sialylation
leads to damage of the muscle tissue, which can be
improved by sialic acid in a mouse model of the disease
[27]. The same mechanism has also been shown to be
operative in myoblasts from patients with GNE myopathy
[7,10]. Thus, it is likely that hyposialylation precedes and is
associated with a cell stress response around αB-crystallin













































































































Figure 6 Subtype analysis of morphologically altered fibres in
GNE myopathy. A subtype analysis of the serial stainings from
Figure 3 was performed in all GNE myopathy samples. Quantification
of immunohistochemical staining of markers of degeneration,
inflammation and cell stress in atrophic fibres (A), fibres with





























































Figure 5 Subtype analysis of GNE myopathy muscle fibres
without structural abnormalities. A subtype analysis of the serial
stainings from Figure 3 was performed in all GNE myopathy
samples. A) A representative fibre appearing normal by H&E staining
(black arrow, left micrograph) displays overexpresssion of αB-crystallin
per immunohistochemical staining (white arrow, right micrograph). B)
A representative fibre appearing normal by H&E staining (black arrow,
left micrograph) displays overexpresssion of iNOS per
immunohistochemical staining (white arrow, right micrograph). C)
Quantitative analysis of serial stainings in all GNE myopathy subjects
reveals that αB-crystallin and iNOS are the most prevalent markers in
normal appearing muscle fibers (data presented as mean plus SEM).
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Taken together, we here demonstrate that αB-crystallin
and iNOS are early markers of a cell stress response in
skeletal muscle fibers of GNE myopathy patients. Their
presence and co-localization in normal appearing fibers
suggests that they take precedence over accumulation of
β-amyloid and formation of vacuoles. Despite absence of a
Fischer et al. BMC Neurology 2013, 13:24 Page 9 of 9
http://www.biomedcentral.com/1471-2377/13/24cellular immune response, mRNA-expression of several
inflammatory markers is present in GNE myopathy and
some of them significantly correlated with αB-crystallin
on the one hand and with APP on the other. Further
evaluation of cell stress mechanisms in GNE myopathy
may help to better understand the pathology of the disease
and provide a useful tool for preclinical assessment of
treatment strategies.
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